


To provide a stable and consistent return through direct and indirect investment mainly in European securities (excluding the United Kingdom).
| Name | % Net Assets | 
|---|---|
| Nestle | 4.7% | 
| Sanofi | 4.4% | 
| Bureau Veritas | 3.6% | 
| Anheuser-Bush Inbev | 3.5% | 
| Swedish Match | 3.2% | 
| Fresenius Medical Care | 3.0% | 
| Tag Immobilien | 3.0% | 
| SAP | 3.0% | 
| Schneider Electric | 2.8% | 
| Total | 2.8% | 
| Key | % Net Assets | 
|---|---|
| 4.7% | |
| 4.4% | |
| 3.6% | |
| 3.5% | |
| 83.8% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 01/08/1981 | 
|---|---|
| Fund Manager | Catie Wearmouth | 
| TER | 1.67 (31-Jan-2014) | 
| Minimum Investment | |
|---|---|
| Initial | 1000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 5.00% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.03 | 
| Sharpe ratio | 0.08 | 
You are here: research